SCHEMBL295012

SCHEMBL295012

[CH2]C(COCC)OCC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11260616 0.82 HSD17B10 (0.34)
SCHEMBL2070625 0.79 TSHR (0.33)
SCHEMBL433670 0.78
SCHEMBL1136403 0.78
SCHEMBL14921241 0.77 ALDH1A1 (0.35)
SCHEMBL1019320 0.76 ALDH1A1 (0.38)
SCHEMBL8976908 0.75 USP2 (0.48)
SCHEMBL20006 0.73
SCHEMBL9335108 0.73
SCHEMBL294499 0.72 LMNA (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 82 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4960873-A 3-pyridylisothiazoleazo compounds useful as disperse dyes BASF AKTIENGESELLSCHAFT (DE) 1990-10-02 US claimed
US-20230348438-A1 PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC. (JP) 2023-11-02 US disclosed
US-20200317644-A1 PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC (JP) 2020-10-08 US disclosed
CN-111732569-A Liquid crystalline compound having dibenzothiophene ring, liquid crystal composition, and liquid crystal display element 捷恩智株式会社 2020-10-02 CN disclosed
CN-111718332-A 2-substituted pyrazol amino-4-substituted amino-5-pyrimidine formamide compound, composition and application thereof 北京赛特明强医药科技有限公司 2020-09-29 CN disclosed
EP-3524599-A1 PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF Japan Tobacco Inc. (JP) 2019-08-14 EP disclosed
US-20180346449-A1 PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF JAPAN TOBACCO INC (JP) 2018-12-06 US disclosed
EP-3199533-A1 PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF Japan Tobacco Inc. (JP) 2017-08-02 EP disclosed
EP-3057958-A1 AMINOTETRALINE AND AMINOINDANE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY AbbVie Deutschland GmbH & Co. KG (DE) 2016-08-24 EP disclosed
EP-3057960-A1 AMINOCHROMANE, AMINOTHIOCHROMANE AND AMINO-1,2,3,4-TETRAHYDROQUINOLINE DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM, AND THEIR USE IN THERAPY AbbVie Deutschland GmbH & Co. KG (DE) 2016-08-24 EP disclosed
US-5163996-A Herbicides CIBA-GEIGY CORPORATION (US) 1992-11-17 US disclosed
EP-0510719-A1 Benzimidazole derivatives substituted with a radical group and their use for inhibiting gastric acid secretion AKTIEBOLAGET HÄSSLE (SE) 1992-10-28 EP disclosed
US-5051413-A For treatment of ischemia, antispasmodic agents, anticonvulsants and anxiety or manic conditions CIBA-GEIGY CORPORATION (US) 1991-09-24 US disclosed
US-4960873-A 3-pyridylisothiazoleazo compounds useful as disperse dyes BASF AKTIENGESELLSCHAFT (DE) 1990-10-02 US disclosed
EP-0335234-A2 Azo isoathiazole dyes BASF Aktiengesellschaft (DE) 1989-10-04 EP disclosed
EP-0302826-A2 Process for the preparation of unsaturated amino acid compounds CIBA-GEIGY AG (CH) 1989-02-08 EP disclosed
EP-0233154-A2 Unsaturated amino-acids CIBA-GEIGY AG (CH) 1987-08-19 EP disclosed
EP-0162217-A1 1,2,4-Triazacycloalcadiene derivatives CIBA-GEIGY AG (CH) 1985-11-27 EP disclosed
EP-0157259-A1 3-Mercapto-1,2,4-triazacycloalcadiene derivatives CIBA-GEIGY AG (CH) 1985-10-09 EP disclosed
US-4451471-A Certain 2,4,5-tri-substituted thiazoles, pharmaceutical compositions containing same and methods of using same CIBA-GEIGY CORPORATION (US) 1984-05-29 US disclosed